DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tasisulam is an investigational drug.
There have been 11 clinical trials for Tasisulam. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Melanoma, Carcinoma, Non-Small-Cell Lung, and Breast Neoplasms. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Recent Clinical Trials for Tasisulam
|A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients||Eli Lilly and Company||Phase 1|
|A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma||Eli Lilly and Company||Phase 1|
|A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma||Eli Lilly and Company||Phase 3|